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ABSTRACT 
The activity of the two related complexes [Cp*Ir(IMe)2X]BF4 (X = Cl (1), H (2)) in transfer-
hydrogenation from iso-propanol to acetophenone was investigated. These studies suggest that the 
commonly accepted monohydride mechanism for transfer-hydrogenation mediated by 
cyclopentadienyl iridium species does not apply to chloride 1. We have found evidence that while 
the two monodentate NHC ligands are retained in the coordination sphere, the Cp* fragment is 
completely released under mild conditions in a precatalytic activation step.  Synthesis of modified 
versions of the initial precatalyst 1 with different cyclopentadienyl and NHC ligands demonstrated 
that increasing the steric pressure around the iridium center facilitates precatalyst activation and 
thus enhances the catalytic performance. Study of five new iridium(III) complexes bearing mono 
or diphosphines helped us monitor Cp* ligand loss under mild conditions. An unusual P-C bond 
cleavage was also noted in a 1,2-bis(dimethylphosphino)methane (dmpm) ligand. Based on these 
findings, a novel catalyst activation mechanism is proposed for [(η5-C5R5)Ir] transfer-
hydrogenation based on the lability of the cyclopentadienyl ligand. 
 
 
 
INTRODUCTION 
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Catalytic hydrogen transfer reactions provide an attractive alternative to direct hydrogenation of 
a broad variety of substrates avoiding the need for molecular hydrogen.1 Furthermore, the 
reversible nature of the ionic H+/H- transfer2 has been exploited in ‘borrowing-hydrogen’ 
processes3-6 for the formation of C-C, C-N and C-O bonds and also for the racemization of 
alcohols. Although transfer-hydrogenation reactions have been known for more than a century,7 
the first homogeneous catalytic systems did not appear until the late 1960s and were based on 
iridium compounds,8-10 still one of the most widely used metals today.11 The introduction of the 
versatile Cp*Ir catalyst precursors for these transformations was independently reported in the 
2000s by Ikariya and Noyori12,13 and Fujita and Yamaguchi.14 Since then, there has been a dramatic 
increase in the number of Cp*Ir systems active for a wide variety of transfer-hydrogenation 
reactions,15 and more recently the list has been enlarged to include very effective species 
containing N-heterocyclic carbene (NHC) ligands.16,17 Several Cp*Ir precatalysts are currently 
commercially available, and the first industrial applications have been reported.18 
Despite the importance of Cp*Ir compounds as precatalysts for transfer-hydrogenation 
reactions, we still have little insight into the effects of ligand substitution at the Cp*Ir fragment. 
In a previous contribution we studied a small library of Cp*Ir catalysts in hydrogen-transfer from 
alcohols to ketones,19 comparing a number of spectator ligands under various reaction conditions. 
A novel Cp*Ir complex containing two minimally substituted, monodentate NHC ligands (1 in 
Fig. 1) emerged as the most active precatalyst in the presence of KOH. We were able to rule out 
contributions from heterogeneous iridium metal, to show that both of the IMe (1,3-dimethyl-
imidazol-2-ylidene) ligands were needed for efficient turnover, and to investigate the kinetics of 
the reaction. Additionally, a stable monohydride derivative (2), often considered a key 
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intermediate in these reactions, could be isolated and found to be an active precatalyst for transfer-
hydrogenation of acetophenone from excess iso-propanol in the presence of KOH. 
 
Figure 1. Cp*Ir precatalysts for transfer hydrogenation from alcohols to ketones.19 
Two mechanisms are commonly proposed for metal-catalyzed transfer-hydrogenation 
reactions:20 i) the hydridic route and ii) direct hydrogen transfer. In the former case a metal hydride 
is involved in the hydrogen transfer step, whereas in the latter the metal facilitates direct hydride 
transfer between substrate and product by providing a six-membered cyclic transition state (A in 
Fig. 2). The direct pathway was initially proposed for the Meerwein-Ponndorf-Verley (MPV) 
reduction,9,21 although recent computational work also supported its relevance to some iridium-
based systems.22 Nevertheless, hydridic mechanisms are most commonly proposed for transition 
metal catalyzed reactions. These have been further divided into monohydride or dihydride classes, 
where the former has been shown to operate both by inner-sphere (B)20 and, less frequently, outer-
sphere (C) pathways.23  
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Figure 2. Key intermediates in common transfer hydrogenation reaction mechanisms: direct 
hydrogen transfer (A); inner-sphere monohydride route (B); outer-sphere monohydride route (C). 
Ln denotes non-functional spectator ligands. 
The commonly accepted mechanism for Cp*Ir-catalyzed hydrogen transfer reactions is the 
monohydride route (either inner or outer-sphere),24,22,25 that assumes full retention of all ancillary 
ligands,20 although the dihydride pathway has less frequently been proposed.17 In our previous 
work, the kinetics of the reaction with 1 were found to be unexpectedly complex and H/D 
scrambling experiments, often used to probe the mechanism of these reactions,26 gave inconclusive 
results. We thus felt that the mechanism of hydrogen transfer catalysis with these complexes 
required a closer look in order to unravel the role of monohydride 2 in catalysis. Here we provide 
new experimental data that rule out the classic routes for our Cp*IrIII systems and suggest a new 
alternative pathway for this type of catalyst. 
 
 
RESULTS AND DISCUSSION 
In the full cycle of the classical base-assisted monohydride pathway of Scheme 1,26 the hydride 
is delivered by the metal and the proton shuttled by an external base. Under reaction conditions, 
the chloride precursor 1 is converted into the alkoxide complex D, which undergoes β-H 
elimination (BHE) to generate the monohydride species 2. Hydride delivery (HDE) from 2 would 
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then provide alkoxide complex D’, and after product dissociation either precatalyst 1 or alkoxide 
species D is regenerated. An important aspect of this mechanism is that the two main steps, namely 
BHE and HDE, generally require the presence of two adjacent vacant sites on the iridium.27 
However, both alkoxide D and hydride 2 are coordinatively and electronically saturated, and we 
have previously shown that both IMe ligands are needed for good catalytic performance and thus 
likely retained throughout the cycle. Outer-sphere Noyori-type monohydride pathways circumvent 
substrate coordination to the metal through concerted LH+/MH- transfer and thus proceed with one 
open site on the metal (C in Fig. 2),23 however this metal-ligand cooperation seems rather unlikely 
with the ligand framework of 1. Cp* has been suggested to be able to act as a transient inner-sphere 
base28 to facilitate formation of the required IrIIIH in a Noyori-type mechanism based on DFT 
calculations, but experimental evidence for such a mechanism has not been found yet. In related 
coordinatively saturated [(arene)RuLn]
+ catalysts, η6-η4 ring slippage of the arene has been 
proposed to allow for the formation the corresponding monohydride from alkoxide 
intermediates.29 In another related case, a Ru-OMe unit is converted into its Ru-H analog 
presumably via ring slippage.30 
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Scheme 1. Inner-sphere monohydride mechanism of base-assisted hydrogen transfer from 
alcohols to ketones mediated by Cp*Ir(NHC)2 complexes (B = base). 
Mechanistic Studies 
In all scenarios following the mechanism shown in Scheme 1, both hydride 2 and halide 1 would 
be in-cycle intermediates, and as such should provide similar performance in catalysis. However, 
while 2 provided some activity in transfer hydrogenation catalysis, it was clearly less efficient than 
1 and gave a different degree of H/D scrambling in the reduction of acetophenone by iso-
propanol.19 Comparing reaction profiles at 60 ºC further corroborated the considerably lower 
activity of monohydride 2 with respect to chloride 1 (Figure 3). Similar observations made 
previously for [(arene)Ru] transfer-hydrogenation catalysts have led to the conclusion that the less 
active monohydride was not a catalytic intermediate.31,32 Additional interesting results emerged 
from these data: i) whereas 1 required a base to be active in catalysis, the efficiency of the related 
hydride was unchanged in its absence; (ii) while transfer-hydrogenation catalyzed by 1 exhibits a 
characteristic induction period of several minutes, as previously reported,19 compound 2 was 
immediately active. This result suggests that a preactivation step is required only for catalysis with 
1, while monohydride 2 is either an active species itself or gives easier access to an active catalyst; 
iii) Using a 1:1 mixture of 1 and 2 did not improve the catalytic performance, instead the overall 
rate was just the sum of the independent profiles for 1 and 2. This finding disfavors a bimolecular 
mechanism involving hydride 2, suggesting that each complex may operate in distinct cycles. 
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Figure 3. Reaction profiles of transfer hydrogenation of acetophenone from excess iso-propanol 
with 1 and 2 in the presence and absence of base at 60 ºC. Reaction conditions: 2 mmol substrate, 
1 mol% [Ir], 3 mL iPrOH, 60 ºC, N2 (
1H NMR analysis with 1,3,5-trimethoxybenzene as internal 
standard). 
We previously synthesized monohydride 2 by the reaction of 1 with NaBH4, but we have now 
attempted to prepare 2 from alkoxides relevant to catalysis to investigate the viability of β-H 
elimination (see Scheme 1). When heating a solution of 1 in iPrOH with excess potassium 
hydroxide the reaction mixture quickly turned dark red, as also seen in the early stages of catalysis 
with 1 in the presence of substrate. However, we were unable to isolate or characterize alkoxide 
derivatives of 1 either with iso-propanol or methanol. Even with alcohols lacking β-hydrogens 
such as tert-butanol or catechol at low temperature and under inert atmosphere, the expected 
alkoxides could not be observed by 1H NMR. We did, however, detect a number of distinctive 
high-field 1H NMR signals characteristic of metal hydrides in the region from -15.5 to -16.5 ppm 
after heating 1 in the presence of excess NaiOPr (Figure 4). The number and distribution of 1H 
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NMR peaks in this region was dependent on the solvent employed. Among the hydride species 
observed, compound 2 was present as a minor reaction product (ca. 20 %) when the reaction was 
carried out in CD2Cl2 (Figure 4B). When the same reaction was performed in iso-propanol (Figure 
4D), the hydridic region of the 1H NMR spectrum  displayed peaks related to those observed after 
a transfer-hydrogenation catalytic run using 1 (Figure 4E). This suggests that the catalytically 
active species is related to one (or several) of these iridium hydrides. In contrast, the related hydride 
2 remained essentially unaltered under similar catalytic conditions even after full conversion of 
100 equivalents of acetophenone to 1-phenylethanol (Figure 4F and 4G). We cannot exclude 
compound 2 being one of the competent intermediates in catalysis by 1, but one or several of the 
other iridium-hydrides generated under the reaction conditions likely exhibits considerably 
enhanced catalytic activity thereby dominating the catalytic performance of the much more active 
precatalyst 1. Moreover, the fact that we do observe reduction of acetophenone mediated by the 
hydrido species 2, albeit in lower yield, indicates either a dissimilar mechanism operating for 
hydride 2 versus chloride 1, or partial decomposition of the former to generate very small amounts 
(below the NMR detection limit) of an alternative active species. 
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Figure 4. 1H NMR hydride region of in-situ reactions carried out in sealed NMR tubes using TMB 
as internal standard. (A) A solution of 1 and iPrONa (5 equiv) in CD3CN heated at 60 ºC for 1 
hour; (B) A solution of 1 and iPrONa (5 equiv) in CD2Cl2 heated at 45 ºC for 3 hours; (C) 
Compound 2 in CD2Cl2; (D) A solution of 1 and 
iPrONa (5 equiv) in iPrOH heated at 60 ºC for 1 
hour; (E) Catalytic transfer-hydrogenation from iPrOH (1 mL) to acetophenone (78 μL) in the 
presence of 1 (1 mol %) and KOH (10 mol %) after 3 hours at 60 ºC (99 % ketone reduction); (F) 
Catalytic transfer-hydrogenation from iPrOH (1 mL) to acetophenone (78 μL) in the presence of 2 
(1 mol %) and KOH (10 mol %) prior to heating (0 % ketone reduction). (G) Catalytic transfer-
hydrogenation from iPrOH (1 mL) to acetophenone (78 μL) in the presence of 2 (1 mol %) and 
KOH (10 mol %) after 3 hours at 60 ºC (55 % ketone reduction). 
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In our prior report19 we made use of the deuterium labeling strategy proposed by Bäckvall and 
co-workers to distinguish monohydride and dihydride mechanisms.26 The results showed different 
degrees of deuterium incorporation at the carbonyl carbon in the product depending on the 
precatalyst used, 1 or 2, suggesting different mechanisms for each. Here we extend the comparison 
by investigating the electronic influence of different substituents on the substrate, kinetic isotopic 
effects (KIEs), and selectivity towards reduction of C=O versus C=C bonds. Table S1 (see 
supporting information) summarizes our results for transfer-hydrogenation from iso-propanol to 
para-substituted acetophenones. Whereas chloro- and iodo-derivatives were completely reduced 
using 1, 89 % conversion was measured for the methoxy-substituted ketone under the same 
conditions, suggesting that electron-donating substituents have a detrimental effect on catalytic 
performance. To analyze this trend in more detail we performed Hammett studies33 under 
competitive and non-competitive conditions with a number of para-substituted acetophenones 
(Figure 5, Figure S1 and Table S2).19 The positive slopes of the observed Hammett correlations 
under non-competitive conditions (1.68 and 1.91 for 1 and 2, respectively) indicate that in both 
cases negative charge is built up in the transition state of the turnover limiting step (TLS), 
consistent with a hydride delivery pathway such as HDE in Figure 2 being the TLS. As expected, 
similar results were obtained under in situ competitive conditions (1.65 and 1.94 for 1 and 2, 
respectively). Kinetic isotopic effects (KIEs) are also consistent with this hypothesis. Under non-
competitive conditions the primary KIEs measured were 2.2 ± 0.2 and 2.1 ± 0.2 for 1 and 2, 
respectively, and slightly lower but similar values (1.8 (1) and 1.9 (2) ± 0.2) were obtained under 
competitive conditions (see Experimental Part for details). 
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Figure 5. Hammett plots for catalysts 1 (blue) and 2 (red) obtained from non-competitive 
experiments for the transfer hydrogenation from isopropanol to p-substituted acetophenones (for 
details see the Supporting Information). 
Next, the chemoselectivity of both catalysts towards reduction of C=O and C=C bonds was 
examined. In our previous report we observed that α,β-unsaturated ketones were completely 
reduced to their saturated alcohols using complex 1.19 Here we demonstrate that the reduction of 
C=C bonds is not restricted to conjugated substrates. Under our standard transfer-hydrogenation 
conditions (1 mol % [Ir], 10 mol % KOH, 60 ºC) styrene was converted into ethylbenzene in ca. 
50 % yield after 5 hours using precatalyst 1, whereas monohydride 2 showed no conversion under 
identical conditions (Scheme 2). Accordingly, complex 1 was able to reduce both C=O and C=C 
bonds of 5-hexen-2-one to yield 2-hexanol as the major product (ca. 85 %), along with minor 
amounts (ca. 8 %) of 5-hexen-2-ol and other unidentified species (Scheme 2). However, hydride 
2 cleanly provided the olefinic alcohol as the main product in 95 % yield. While the selectivity 
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exhibited by 2 is in accordance with a classic catalyst proceeding through monohydride pathways, 
the ability of precatalyst 1 to reduce non-activated C=C bonds suggest the involvement of 
polyhydride species.19 
 
Scheme 2. Selective reduction of C-O versus C-C bonds 
 
Comparing the lability of Cp* versus NHC 
The collective evidence suggesting differential reactivity between 1 and 2 rules out a traditional 
monohydride mechanism for compound 1, because 2 would be an intermediate in either cycle. 
Since the H/D scrambling results and C=C vs. C=O selectivity data suggested the involvement of 
multiple hydrides in the more efficient precatalyst 1, we became dissatisfied with the standard 
monohydride mechanisms. Alternatively, formation of a dicationic Ir(V) dihydride intermediate 
might be proposed, but we believe that generation of such an species would not be favored under 
basic conditions due to the expected high acidity of the hydrides. Besides, it would not take into 
account the marked differences in reactivity between compounds 1 and 2.  
The loss of a C-donor ligand is not normally considered in mechanistic discussions of Cp*Ir-
based catalysts, but some ligation rearrangement in 1 had to be operational to allow for the 
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formation of polyhydride species. To probe the relative lability of the NHCs versus the Cp* ligand, 
we introduced strongly binding phosphines to enhance steric stress around the metal to induce loss 
of the most easily dissociable ligand.40,41 The reaction of compound 1 with excess PMe3 and 
Me2PCH2PMe2 (dmpm) at room temperature resulted in substitution of the chloride anion and 
formation of corresponding dicationic complexes 3 and 4, which retain all the C-donor ligands 
(Scheme 3). Compound 3 is characterized by the appearance of a resonance in the 31P{1H} NMR 
spectrum at -46.9 ppm, whereas 4 displays two doublets at -38.7 and -53.1 ppm with a two-bond 
coupling constant of 34.9 Hz. In the 1H NMR spectra a distinctive peak due to the Cp* ligand 
appears at 1.86 and 1.71 ppm for compounds 3 and 4, respectively, exhibiting characteristic four-
bond coupling to phosphorus of 2.3 Hz. The hindered rotation of the NHC ligands due to steric 
pressure brought by the phosphines is evidenced by the inequivalence of the backbone protons of 
the IMe ligands in the room temperature 1H NMR spectra of 3 and 4 as opposed to the less 
congested complexes 1 or 2. Compound 3 is stable to air in both the solid state and in solution. In 
contrast, exposure of solutions of 4 to air results in quantitative oxidation of the pendant phosphine 
(t1/2 ≈ 3 hours with stirring) to yield complex 5. A characteristic strongly deshielded 31P{1H} 
resonance at 41.4 (d, 2JPP = 29 Hz) was recorded for 5, confirming the formation of the phosphine 
oxide. The complete air-stability of 4 and the clean mono-oxidation of dmpm in 5 suggest that the 
phosphines remain tightly bound even in solution. Analysis of single crystals of 3 and 5 by X-ray 
diffraction (Figure 6) confirmed all structural features expected from the solution-phase NMR 
analysis. They display the standard piano-stool geometry and show typical Ir-P and Ir-CNHC bond 
lengths, with values of 2.327(1) and 2.337(2)Å, for the Ir-P bonds of 3 and 5, respectively, and 
2.048(4), 2.089(4)Å and 2.031(7), 2.079(8)Å for the Ir-CNHC bonds. 
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Scheme 3. Synthesis of dicationic phosphine derivatives of 1. 
 
1.  
Figure 6. ORTEP diagrams of the cationic portions of compounds 3 and 5. 50 % thermal ellipsoids 
are shown. Hydrogen atoms and solvent molecules have been omitted for clarity. 
Heating methanol solutions of 3 under nitrogen at 60 ºC with excess PMe3 (up to 50 equiv.) did 
not affect the integrity of the complex. Similarly, heating a solution of 4 at the same temperature 
did not result in any observable transformation or dynamic processes via 1H or 31P NMR 
spectroscopy. However, heating complex 4 with one additional equivalent of dmpm to 60 ºC 
3 5 
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resulted in complete disappearance of 1H and 31P{1H} NMR signals diagnostic of 4 within 10 min. 
The major product of the reaction (6 in Scheme 4) resulted from dissociation of the Cp* ligand, 
while both NHCs remained bound to iridium. Compound 6 gives rise to four inequivalent signals 
in the 31P{1H} NMR spectrum (-43.1 (ddd, 2JPP = 63, 21, 18 Hz), -55.2 (ddd, 
2JPP = 63, 
4JPP = 21, 
2 Hz,), -76.0 (ddd, 2JPP = 26, 
4JPP = 21, 2 Hz), -93.4 ppm (m)), and a 
1H NMR high-field resonance 
at -14.8 ppm characteristic of an Ir−H with the expected coupling to the four phosphorus centers 
(ddt, 1 H, 2JHP = 150.0, 20.5, 5.3, 
4JHP = 5.3 Hz). No peak arising from bound Cp* was present, 
whereas signals corresponding to the NHC fragments remained with only minor changes in the 
chemical shift from 4.  A minor species found in this reaction (7 in Scheme 4) resulted from the 
substitution of the pendant CH2PMe2 fragment by an OMe group from the solvent, and was 
characterized by its three 31P{1H}  resonances (54.4, -73.6 and -92.2 ppm) and a high field peak at 
-15.4 ppm in the 1H NMR spectrum.  Compound 6 could be isolated from the mixture as a pure 
white microcrystalline material by layering the methanol solution with diethyl ether. The structures 
of compounds 6 and 7 were further confirmed by X-ray diffraction, confirming complete 
displacement of the Cp* fragment (Figure 7). The hydride ligand appears bound to the iridium 
center trans to one of the phosphorus atoms of the chelated phosphine, whereas both NHCs are 
also trans to phosphorus. In both complexes, Ir-P and Ir-CNHC distances have normal values. 
 
Scheme 4. Reaction of 4 with dmpm and subsequent Cp* displacement. 
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Figure 7. ORTEP diagrams of compounds 6 and 7. 50 % thermal ellipsoids are shown. Hydrogen 
atoms (except Ir-H), counterions and solvent molecules have been omitted for clarity.  
NHC dissociation by reductive elimination or ligand substitution is well documented,34 a 
pathway that often has implications in catalysis.35 However, our kinetic evidence that both IMe 
ligands are required for efficient catalysis (as reported in our prior paper19) along with the observed 
displacement of Cp* in compound 4 made us consider its possible loss under transfer-
hydrogenation conditions. Cp* degradation in transition metal complexes has been reported under 
oxidative conditions,36 but its dissociation is much less common in reducing or neutral 
environments. Main group complexes commonly display a variable hapticity of the Cp ligand37,38 
and frequently act as Cp transfer reagents.39 Ring-slippage of η5-C5H5 to η3 and η1-C5H5 is also 
well documented for a variety of transition metal complexes.40 For instance, Casey found that in 
the presence of excess PMe3, [η5-(C5H5)Re(CH3)(NO)(PMe3)] is in equilibrium with related η3- 
and η1-C5H5 species, and the Cp is eventually released as (C5H5)- anion.41 Although dissociation 
of Cp* is less frequent, it has been reported occasionally.42 Cp* complexes of the rare earths are 
more ionic, and steric crowding can lead to dissociation of (Me5C5)
-.43 We speculate that the 
formation of the iridium-hydride 6 might involve initial ring-slippage from η5 to η1-C5Me5 
followed by β-H elimination to release a neutral fulvene species, although we cannot yet be sure.44 
6 7 
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To the best of our knowledge this is the first example of dissociation of a Cp* ligand from an 
iridium complex to generate a single major product under mild conditions. 
The fact that the Cp* ligand in compound 1 can be rapidly released using 2 equivalents of dmpm 
under mild heating may have direct implications in catalysis. The reaction of 1 and dmpm clearly 
indicates that the Cp* fragment in 1 is more labile than the NHC ligands, and that it prefers to 
dissociate completely rather than slip reversibly when sterically stressed. As discussed above, 
catalysis by 1 likely requires dissociation of one of the ligands that are usually considered 
spectators, Cp* or the NHCs, to produce the required vacant coordination sites. Although the 
reactivity displayed by 1 in the presence of phosphines or under iPrOH/KOH is not directly 
comparable, it is consistent with all our data to postulate that release of the Cp* rather than the 
NHC occurs during transfer-hydrogention. In fact, heating an iso-propanol solution of 1 in the 
presence of KOH (10 equiv) not only resulted in the appearance of several 1H NMR resonances 
due to Ir-H units (vide supra), but also the rapid disappearance of the intense singlet at 1.65 ppm 
corresponding to bound Cp*. As before and in accord with related reports,42a-c all efforts to 
determine the chemical structure of the Cp* after release were unfruitful (including in-situ spiking 
of NMR samples with different Cp* derivatives, mass spectrometry and attempted separation by 
column chromatography for further spectroscopic analysis). Nevertheless, we were able to obtain 
useful indications from mass spectrometry analysis (FT-ICR) of a post-catalytic transfer-
hydrogenation mixture. This showed a set of peaks consistent with the presence of 
[IrIII(IMe)2(H)2]
+, a species in which Cp* loss has occurred (Figure S5; m/z = 385.1129 and 
387.1151; calcd for C10H18IrN4
+ = 385.1137 and 387.1161). Importantly, no Cp*Ir species was 
detected in this MS analysis. In our prior work19 we described how molecular oxygen has a 
detrimental effect on the catalytic activity of 1. Related to this, another set of peaks in the mass 
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spectrum indicates oxidation of the postulated dihydride species (Figure S5; m/z = 399.0922 and 
401.0946; calcd. for C10H18IrN4O
+ = 399.0930 and 401.0953). Taken together, these results 
strongly suggest that the active species in the case of the chloride complex 1 forms through 
dissociation of the Cp*. 
 
Catalyst Preactivation 
To test if the initial lag phase in catalysis with 1 was linked to Cp* loss as a pre-catalytic 
activation step, we set up parallel experiments in sealed NMR tubes. Reduction of acetophenone 
in iPrOH/KOH using 1 mol % of 1 was carried out at 25 ºC. In one case the NMR tube was heated 
at 60 ºC for 30 min prior to the addition of the ketone (Scheme 5). While 1-phenylethanol was 
formed in less than 2 % yield for the 25 ºC sample after 12 hours, 40 % conversion of acetophenone 
was seen from the thermally pre-activated catalyst. Analogous results were obtained when the 
catalytic reactions were monitored at 40 ºC. In this case, the  40 ºC sample gave 8 % conversion, 
while with the 60 ºC pre-activated sample the ketone was reduced in 70 % yield. Thus, the high 
temperatures required for transfer hydrogenation catalyzed by 1 are mainly needed for generating 
a more active iridium species through Cp* release. 
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Scheme 5. Transfer-hydrogenation from iPrOH to acetophenone catalyzed by 1 and thermally pre-
activated 1 (denoted 1*) (heating the reaction mixture at 60 ºC for 30 min prior to the addition of 
acetophenone). 
 
New Catalyst Designs 
To further test our hypothesis, we synthesized other derivatives with modified cyclopentadienyl 
and NHC ligands and tested them as precatalysts under our standard transfer-hydrogenation 
conditions. Compound 8, first reported by Heinekey,45 contains a chelating bis-NHC ligand. 
Compounds 9 and 10 bearing two NHC ligands were prepared via double carbene transfer from 
bis-NHC silver complexes to the corresponding cyclopentadienyl-iridium(III)-chloro dimers 
(Scheme 6, see Experimental Section for details), as previously reported.46,19  
 
Scheme 6. Synthesis of various half-sandwich Ir-NHC complexes. 
Compound 9 displays a distinct 1H NMR resonance at 5.84 ppm due to the C5H5 ring. In contrast 
to complexes 3-5, free rotation around the Ir-CNHC bonds results in averaged signals for the 
 21 
aromatic (7.07 ppm, 4 H) and aliphatic (3.48 ppm, 12 H) hydrogens of the IMe ligands, as in 
complexes 1 and 2. The Cp* ligand in 10 gives rise to an intense, sharp singlet at 1.50 ppm in the 
1H NMR spectrum, whereas signals due to heteroaromatic (7.11 ppm) and aliphatic N-CH2R (3.68 
ppm) hydrogens of the NHC ligands appear as broad peaks at 25 ºC, likely as a result of restricted 
ligand rotation imposed by the greater steric bulk of the IBu ligand with respect to IMe. Variable-
temperature 1H NMR studies previously carried out on 1 showed decoalescence of the IMe signals 
at 223 K.19 In complex 10, the broad signal corresponding to the N-CH2R hydrogens of the NHC 
ligands split into eight resonances below 243 K, with the coalescence temperature reached around 
263 K (see Supporting Information, Figure S2). To quantify the energy barrier associated with the 
ligand rotation we carried out line-shape analysis on compounds 1 and 10 at different temperatures 
and analyzed the different rate constants via a linear free energy plot using the Eyring equation 
(activation parameters summarized in Table 1). As expected, the highest value of ΔG‡ was 
obtained for compound 10 (16.5 ± 0.5 kcal mol-1, ~7 kcal mol-1 higher than in 1), reflecting high 
steric congestion around the metal. Interestingly, while the entropic contribution for compound 1 
was almost negligible, its influence was considerable in compound 10 (ΔS‡ = 15 ± 2 cal mol-1 K-
1), consistent with the idea that Cp* slip is required for ligand rotation in this case. 
 
Table 1. Activation parameters obtained by 1H NMR line-shape analysis and Eyring studies for 
the rotation of NHC ligands in Cp*Ir compounds. 
Compound ΔH‡ (kcal mol-1) ΔS‡ (cal mol-1 K-1) ΔG298‡ (kcal mol-1) 
1 10.4 ± 0.2 2 ± 2 9.8 ± 0.5 
10 21.1 ± 0.2 15 ± 2 16.5 ± 0.5 
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Crystals of complexes 9 and 10 suitable for X-ray diffraction were obtained by diffusion of 
diethyl ether into dichloromethane solution. The ORTEP diagrams of their corresponding cations 
are shown in Figure 8. Both Cp*Ir compounds exhibit geometries typical for these types of systems 
with C-Ir-C and C-Ir-Cl angles of almost 90º. The Ir-CNHC bond lengths in compound 10 are 
slightly longer (2.050(4) and 2.084(4) Ǻ) than in 9 (2.015(7) and 2.065(9) Ǻ), probably due to the 
higher steric congestion around the iridium atom caused by the bulkier aliphatic chains. 
 
Figure 8. ORTEP diagrams of the cationic portions of compounds 9 and 10. 50 % thermal 
ellipsoids are shown. Hydrogen atoms and solvent molecules have been omitted for clarity. 
An interesting geometric feature of compound 10 in the solid state is a significant distortion of 
the Cp* ring (Figure 9). A slightly lower but noticeable distortion was also found previously in 
compound 1,19 and is the likely result of steric crowding from the NHC wingtips. In the crystal, 
the planes of the NHC ligands in 1 are oriented at an angle of ca. 70 º relative to each other, which 
forces one of the N-Me groups to point directly towards the Cp-Me groups, resulting in N-
CH3···H3C(Cp*) distances as short as 1.93 and 2.20 Ǻ (dHH in Figure 9a), compared with the sum 
of the conventional van der Waals radii of 2.4 Å. As a consequence, the methyl groups of the Cp* 
fragment are bent out of the plane of the cyclopentadienyl ring. Distortions of the methyl carbon 
9 
10 
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atoms out of the Cp* plane range from 0.17 to 0.27 Ǻ (δ in Figure 9b). In 10 this distortion is 
clearly larger, with dHH up to 2.35 Ǻ and δ from 0.15 to 0.48 Ǻ. The hindered NHC rotation in 
solution and Cp* distortion found in the solid state indicate significantly increased steric pressure 
around the iridium as compared to 1. Although there are other examples of this kind of Cp* 
distortion in iridium compounds,47 usually in the presence of bulky ligands such as tert-butyl 
phosphines, to our knowledge this is the highest distortion of this type reported for a mononuclear 
iridium compound. The few reported examples with slightly higher δ values include polymetallic 
species48 or compounds in which the hapticity of the Cp* is considered to switch from η5 to η4.49 
 
Figure 9. Solid-state structure of compound 10 emphasizing the distortion of the Cp* ring: (a) dHH 
= shortest H-H distances between Cp* and a butyl chain; (b) δ = distance from the methyl groups 
of the Cp* to the cyclopentadienyl ring plane formed by the cyclopentadienyl ring (butyl chains 
truncated). 
In contrast, in the X-ray crystal structure of complex 845 the N-CH3 termini are farther from the 
Cp* than in 1 or 10, due to the different orientation brought about by the methylene linker, with 
the shortest dHH distances being only ~2.6 Ǻ (0.5-0.6 Ǻ longer than in 1 and 10). Consequently, 
no distortion of the Cp* ligand is observed. In compound 9 the shortest dHH distance is 2.25 Ǻ, 
(a) (b) 
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also indicative of some steric congestion around the iridium center, but to a much lesser extent 
than for 1 or 10. 
The catalytic activities of compounds 8, 9 and 10 in transfer-hydrogenation from iso-propanol 
to acetophenone were then investigated to test whether the different degrees of steric congestion 
would translate into different catalytic activity. The consumption of acetophenone was monitored 
by in-situ 1H NMR spectroscopy at 60ºC, and the results are summarized in Figure 6. While 
catalyst 1 exhibits an induction period of around 15 min under these conditions (Figure 10), 
increasing the steric hindrance around the metal center in compound 10 resulted in a considerable 
reduction of the lag phase to less than one minute, leading to complete consumption of the ketone 
substrate within 20 min (ca. 90 min using 1). On the other hand, substitution of the C5Me5 ring of 
1 by the less bulky C5H5 in 9 resulted in a remarkable enhancement of the non-productive induction 
period to ca. 90 min. This lag phase trend is perfectly consistent with higher steric pressure around 
Ir being favorable to the ligand loss required for precatalyst activation. If a purely ring-slippage 
mechanism prevailed, compound 9 would be expected to be more active than 1,37a which is clearly 
not the case for these bis-NHC iridium complexes. In contrast, complex 8 did not display any 
observable induction period, although its catalytic performance was rather poor. As discussed 
above, the more planar geometry of the linked-bis-NHC ligand might not induce Cp* release in 
the way freely rotating monodentate NHCs would, and the proposed activation route based on 
complete Cp* loss would remain inaccessible. 
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Figure 10. Profiles of acetophenone consumption monitored by 1H NMR in the transfer-
hydrogenation-reaction catalyzed by 2 (♦), 8 (▲), 9 (■) and 10 (●) in iPrOH (60 ºC, 1 mol % [Ir], 
10 equiv. KOH, TMB as internal standard). 
A plausible scenario to account for all the observed experimental data would include two distinct 
pathways for all half-sandwich compounds investigated in this and our prior work.19 In compounds 
where the steric pressure of the spectator ligands around Ir is sufficiently high, and the lability of 
those ligands themselves is limited, the η5-cyclopentadienyl moiety can be released to generate 
(poly)hydride complexes, at least one of which is a highly active, although less chemoselective, 
transfer-hydrogenation catalyst. This type of system is characterized by the presence of induction 
periods associated with the ring loss, high catalytic performance after the induction phase, and 
sensitivity to oxygen and moisture. Related to this, Papish and co-workers have recently found that 
the lability of arene ligands in [(η6-C6R6)Ru] catalysts correlates with their activity as transfer-
hydrogenation catalysts.50 In contrast, our iridium precatalysts bearing less sterically demanding 
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ligands, or containing labile ligands such as pyridine, would follow one of the common 
monohydride mechanisms that do not require loss of the cyclopentadienyl ring. These precatalysts 
do not exhibit significant induction periods, and although they operate with lower rates under 
comparable conditions, display moderate stability toward oxygen and moisture. Complex 2 can be 
included into the second class of systems, since, once the monohydride is formed, Cp* loss does 
not seem to occur and no base is required for turnover. Starting with halide precursors such as 1, 
9, or 10 and base, however, the faster cyclopentadienyl loss pathway prevails. The observation that 
the induction period is second order in [Ir]19 and requires KOH appears to point to the involvement 
of hydroxo or alkoxo complexes as activating intermediates, but definite conclusions on this aspect 
cannot yet be drawn. In the future, we hope to clarify further the nature of the activation step and 
the active catalystspecies in these systems. 
 
CONCLUSION 
Cp*Ir compounds are extensively used as catalysts in a broad variety of transfer-hydrogenation 
and hydrogen-borrowing reactions. These compounds have previously been thought to operate via 
mechanisms in which the Cp* fragment remains bound as a robust spectator ligand. At most, 
reversible ring-slippage during catalysis has been postulated. Here we have found evidence that in 
some cases the Cp* ligand can be released under commonly employed transfer hydrogenation 
conditions. Model reactivity studies with phosphines have allowed us to isolate an iridium 
compound in which the Cp* moiety has been displaced by a diphosphine. Spectroscopic 
characterization and X-ray diffraction studies unequivocally demonstrated the loss of the Cp* 
fragment. Our new mechanistic proposal is that increasing the steric congestion in the precatalyst 
shortens the induction periods and thus speeds up catalysis. This effect has been demonstrated in 
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a series of cationic half-sandwich iridium compounds containing two NHC ligands. Remarkably, 
thermal pre-activation of precatalyst 1 provided a species active even at room temperature, where 
the parent complex 1 shows no activity under those conditions. We expect that this type of 
activation may also hold for some of the many known [(η5-C5R5)M] catalysts, not only for transfer-
hydrogenation but also other catalytic reactions where Cp loss may need to be considered as a 
plausible pathway 
. 
EXPERIMENTAL SECTION 
General. Organic solvents were purified by passing over activated alumina with dry N2. All 
chemicals were purchased from major commercial suppliers and used as received. Iso-propanol 
was directly purchased in 100 mL Sure/SealTM bottles and stored over molecular sieves. Syntheses 
were performed under an inert atmosphere of dry N2 using standard Schlenk techniques. NMR 
spectra were recorded on Bruker AMX-400 and -500 spectrometers at ambient probe temperatures 
unless otherwise noted. Chemical shifts are reported with respect to residual internal protio solvent 
for 1H and 13C{1H} NMR spectra and to an external standard for 31P{1H} spectra (85% H3PO4 in 
H2O at δ 0.0 ppm). The chemical shift δ is reported in units of parts per million (ppm). MS analyses 
were performed by the Mass Spectrometry and Proteomics Resource of the W.M. Keck Foundation 
Biotechnology Resource Laboratory at Yale University. Elemental analyses were performed by 
Robertson Microlit Laboratories (Ledgewood, NJ, USA). Compounds (IBu)BF4,
51 1,19 219 and 845 
were synthesized by previously reported procedures. 
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[(η5-C5Me5)IrIII(IMe)2(PMe3)](BF4)(Cl)  (3) 
In the glovebox, PMe3 (12 μL, 0.117 mmol) was added to a solution of 1 (50 mg, 0.078 mmol) 
in dry MeOH (5 mL), and the reaction mixture stirred for 15 min at room temperature, which 
resulted in a color change from dark orange to yellow. Addition of Et2O caused the precipitation 
of compound 3 as a yellow microcrystalline solid (48 mg, 86 %). 1H NMR (500 MHz, CD3OD, 25 
ºC): δ = 7.66 (d, 1H, 3JHP = 2.1 Hz, CHAr), 7.62 (d, 1H, 3JHP = 2.1 Hz, CHAr), 7.52 (d, 1H, 3JHP = 
2.1 Hz, CHAr), 7.39 (d, 1H, 
3JHP = 2.1 Hz, CHAr), 3.90 (s, 3 H, NCH3), 3.87 (s, 3 H, NCH3), 3.24 
(s, 3 H, NCH3), 2.75 (s, 3 H, NCH3), 1.86 (d, 15 H, 
4JHP = 2.3 Hz, C5Me5), 1.68 (d, 9 H, 
2JHP = 
10.2 Hz, IrPMe3). 
1H NMR (500 MHz, DMSO-d6, 25 ºC): δ = 7.76 (d, 1H, 3JHP = 2.0 Hz, CHAr), 
7.68 (d, 1H, 3JHP = 2.1 Hz, CHAr), 7.67 (d, 1H, 
3JHP = 2.1 Hz, CHAr), 7.46 (d, 1H, 
3JHP = 2.0 Hz, 
CHAr), 3.78 (s, 3 H, NCH3), 3.72 (s, 3 H, NCH3), 3.11 (s, 3 H, NCH3), 2.61 (s, 3 H, NCH3), 1.74 
(d, 15 H, 4JHP = 2.2 Hz, C5Me5), 1.157 (d, 9 H, 
2JHP = 10.3 Hz, IrPMe3). 
13C{1H} NMR (125 MHz, 
DMSO-d6, 25 ºC): δ = 137.3 (d, 2JCP = 5 Hz, Ir=C), 135.2 (d, 2JCP = 23 Hz, Ir=C), 127.2, 126.7, 
126.7, 125.3 (CHAr), 101.2 (C5Me5), 41.4, 39.5, 38.9, 38.7 (NCH3), 18.9 (d, 
1JCP = 39 Hz, PMe3), 
10.5 (C5Me5). 
31P{1H} NMR (160 MHz, CD3OD, 25 ºC) : -46.9. Anal. Calcd. for 
C23H40BClF4IrN4P (%): C, 38.47; H, 5.61; N, 7.80. Found: C, 38.87; H, 5.83; N, 7.40. HRMS (FT-
ICR): calcd for C23H40IrN4P
2+ (M2+): 297.1298, 298.1305. Found: m/z = 297.1276, 298.1309. 
Crystal data [CCDC 973858]: C24H44B2F8IrN4OP (3), M = 801.42, Monoclinic, P21/c, a = 10.6139 
(3) Å, b = 10.4084 (3) Å, c = 27.7107 (19) Å, β = 96.783 (7)º, V = 3039.9 (2) Å3, Z = 4, dcalc = 
1.751 g/cm3, T = 150 K, 85717 reflections collected, 6913 independent reflections (Rint = 0.073), 
final R1 = 0.0392, final wR2 = 0.0719, GOF = 1.057. 
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[(η5-C5Me5)IrIII(IMe)2(dmpm)](BF4)(Cl) (4) 
In the glovebox, dmpm (14 μL, 0.086 mmol) was added to a solution of 1 (50 mg, 0.078 mmol) 
in dry MeOH (5 mL), and the reaction mixture stirred for 15 min at room temperature, which 
resulted in a color change from dark orange to yellow. Addition of Et2O caused the precipitation 
of compound 4 as a yellow microcrystalline solid (49 mg, 80 %). 1H NMR (500 MHz, CD3OD, 25 
ºC): δ = 7.51 (d, 1H, 3JHP = 2.1 Hz, CHAr), 7.48 (d, 1H, 3JHP = 2.1 Hz, CHAr), 7.39 (d, 1H, 3JHP = 
2.1 Hz, CHAr), 7.27 (d, 1H, 
3JHP = 2.1 Hz, CHAr), 3.79 (s, 3 H, NCH3), 3.75 (s, 3 H, NCH3), 3.08 
(s, 3 H, NCH3), 2.63 (s, 3 H, NCH3), 1.79 (br. d, 2 H, 
2JHP = 8.6 Hz, PCH2P), 1.71 (d, 15 H, 
4JHP 
= 2.3 Hz, C5Me5), 1.66 (d, 3 H, 
2JHP = 9.9 Hz, IrPMeMe), 1.58 (d, 3 H, 
2J = 9.9 Hz, IrPMeMe), 1.08 
(dd, 2JHP = 10.6, 
4JHP = 3.4 Hz, IrPCH2PMe2). 
13C{1H} NMR (125 MHz, CD2Cl2, 25 ºC): δ = 
139.3, 137.5 (Ir=C), 128.5, 128.2, 128.0, 126.7 (CHAr), 103.5 (C5Me5), 42.3, 40.7, 40.1, 39.8 
(NCH3), 35.4 (br. d, 
1JCP = 35.3 Hz, PCH2P), 17.0 – 16.0 (m, IrPMe2CH2PMe2), 11.1 (C5Me5). 
31P{1H} NMR (160 MHz, CD2Cl2, 25 ºC) : -38.7 (d, 2JPP = 34.9 Hz, Ir−PCH2P), -53.1 (d, 2JPP = 
34.9 Hz, Ir−PCH2P). Anal. Calcd. for C25H45BClF4IrN4P2 (%): C, 38.59; H, 5.83; N, 7.20. Found: 
C, 38.10; H, 5.72; N, 6.83. HRMS (FT-ICR): calcd for C25H45IrN4P2
2+ (M2+): 327.1363, 328.1375. 
Found: m/z = 327.1350, 328.1372. 
[(η5-C5Me5)IrIII(IMe)2(dmpm=O)](BF4)(Cl)  (5) 
A solution of 4 (30 mg, 0.046 mmol) in MeOH (3 mL) was vigorously stirred in air for 24 hours, 
then Et2O was added and compound 5 precipitated as a pale yellow powder (30 mg, 97 %).
1H 
NMR (500 MHz, CD3OD, 25 ºC): δ = 7.66 (d, 1 H, 3JHP = 2.1 Hz, CHAr), 7.62 (d, 1 H, 3JHP = 2.1 
Hz, CHAr), 7.54 (d, 1 H, 
3JHP = 2.1 Hz, CHAr), 7.41 (d, 1 H, 
3JHP = 2.1 Hz, CHAr), 3.91 (s, 3 H, 
NCH3), 3.88 (s, 3 H, NCH3), 3.20 (s, 3 H, NCH3), 2.77 (s, 3 H, NCH3), 2.52 (m, 2 H, PCH2P), 
1.96 (d, 3 H, 2JHP = 10.0 Hz, IrPMeMe), 1.94 (d, 3 H, 
2J = 10.1 Hz, IrPMeMe), 1.85 (d, 15 H, 
4JHP 
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= 2.5 Hz, C5Me5), 1.74 (dd, 
2JHP = 13.3, 
4JHP = 7.4 Hz, IrPCH2P(O)Me2). 
1H NMR (500 MHz, 
DMSO-d6, 25 ºC): δ = 7.71 (d, 1 H, 3JHP = 2.0 Hz, CHAr), 7.62 (d, 1 H, 3JHP = 2.0 Hz, CHAr), 7.61 
(d, 1 H, 3JHP = 2.0 Hz, CHAr), 7.41 (d, 1 H, 
3JHP = 2.1 Hz, CHAr), 3.76 (s, 3 H, NCH3), 3.69 (s, 3 
H, NCH3), 3.05 (s, 3 H, NCH3), 2.60 (s, 3 H, NCH3), 2.37 (t, 2 H, 
2JHP = 10.9 Hz, PCH2P), 1.80 
(d, 3 H, 2JHP = 10.4 Hz, IrPMeMe), 1.66 (d, 3 H, 
2J = 10.7 Hz, IrPMeMe), 1.70 (d, 15 H, 
4JHP = 2.3 
Hz, C5Me5), 1.55 (dd, 
2JHP = 13.3, 
4JHP = 6.6 Hz, IrPCH2P(O)Me2). 
13C{1H} NMR (125 MHz, 
DMSO-d6, 25 ºC): δ = 138.9, 138.4 (Ir=C), 127.2, 126.8, 126.7, 125.4, (CHAr), 101.4 (C5Me5), 
40.5, 39.5, 38.9, 38.6 (NCH3), 28.3 (PCH2P), 20.0 – 17.8 (m, IrPMe2CH2P(O)Me2), 10.2 (C5Me5). 
31P{1H} NMR (160 MHz, CD2Cl2, 25 ºC) : 41.4 (d, 2JPP = 29 Hz, Ir−PCH2P(O)), -39.9 (d, 2JPP = 
29 Hz, Ir−PCH2P). Anal. Calcd. for C24H45BClF4IrN4OP2 (%): C, 37.81; H, 5.71; N, 7.06. Found: 
C, 38.07; H, 5.23; N, 6.70. HRMS (FT-ICR): calcd for C20H31IrN4
2+ (M2+ - dmpm(O)): 259.1078, 
260.1089. Found: m/z = 259.1611, 260.1612. Crystal data [CCDC 973859]: C27H53B2F8IrN4O3P2 
(3), M = 909.49, Orthorhombic, P212121, a = 10.2065 (5) Å, b = 11.6450 (5) Å, c = 30.295 (2) Å, 
V = 3600.8 (4) Å3, Z = 4, dcalc = 1.678 g/cm
3, T = 150 K, 92341 reflections collected, 6505 
independent reflections (Rint = 0.104), final R1 = 0.0396, final wR2 = 0.0728, GOF = 1.088. 
Reaction of 2 with two equiv. of dmpm (6, 7) 
Dmpm (49 μL, 0.312 mmol) was added under argon to a solution of 1 (80 mg, 0.125 mmol) in 
dry MeOH (10 mL) and the mixture stirred at 70 ºC for 30 min, which resulted in a color change 
from orange to yellow. 1H and 31P{1H} NMR monitoring of the reaction showed full conversion 
of 1 to a mixture of ca. 95:5 of 6 and 7. The solution was concentrated, layered with Et2O and 
stored at -20 ºC for crystallization. The resulting white crystals were filtered and washed with Et2O 
to give compound 6 as colorless microcrystalline powder (70 mg, 72 %). Elemental analysis was 
obtained for the major compound from crystals grown from Et2O/pentane. Major compound (6). 
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1H NMR (500 MHz, DMSO-d6, 25 ºC): δ 7.60 (dd, 1 H, 3JHH = 2.0, 5JHP = 0.9 Hz, CHAr), 7.51 (d, 
1 H, 3JHH = 1.7 Hz, CHAr), 7.44 (dd, 1 H, 
3JHH = 2.1, 
5JHP = 0.9 Hz, CHAr), 7.40 (d, 1 H, 
3JHH = 1.9 
Hz, CHAr), 4.58 (dt, 1 H, 
2JHH = 15.2, 
2JHP = 10.0 Hz, P(A)CHHP(B)), 3.81 (s, 3 H, N(CH3)), 3.73 
(s, 3 H, N(CH3)), 3.52 (dt, 1 H,
2JHH = 15.2,
  2JHP = 11.5 Hz, P(A)CHHP(B)), 2.87 (s, 3 H, N(CH3)), 
2.86 (s, 3 H, N(CH3)), 2.13 (m, 2 H, P(C)CHHP(D)), 1.93 (d, 3 H, 
2JHP = 8.5 Hz, P(A)MeMe), 1.90 
(d, 3 H, 2JHP = 9.8 Hz, P(B)MeMe), 1.85 (d, 3 H, 
2JHP = 8.3 Hz, P(C)MeMe), 1.67 (d, 3 H, 
2JHP = 8.3 
Hz, P(A)MeMe), 1.45 (d, 3 H, 
2JHP = 10.0 Hz, P(B)MeMe), 1.30 (d, 3 H, 
2JHP = 9.1 Hz, P(C)MeMe), 
1.21 (d, 2JHP = 3.6 Hz, 3H, P(D)MeMe), 1.08 (d, 3 H, 
2JHP = 3.4 Hz, P(D)MeMe), -14.8 (ddt, 1 H, 
2JHP = 150.0, 20.5, 5.3 Hz, Ir−H). 13C{1H} NMR (500 MHz, DMSO-d6, 25 ºC): δ = 153.6 (d, 2JCP 
= 275 Hz, Ir=C), 151.7 (d, 2JCP = 240 Hz, Ir=C), 124.8, 124.7, 123.9, 123.5 (CHAr), 46.1 
(P(A)C2P(B)), 42.1, 41.6, 40.9, 37.3 (N(CH3)), 37.2 (P(C)CH2P(D)), 19.9 (P(A)MeMe), 19.5 
(P(C)MeMe), 18.8 (P(A)MeMe), 18.7 (P(C)MeMe), 15.9 (P(B)MeMe), 15.3 (P(D)MeMe), 15.1 
(P(D)MeMe), 14.7 (P(B)MeMe). 
31P{1H} NMR (160 MHz, CD3OD, 25 ºC):  -43.1 (ddd, 2JPP = 63, 
21, 18 Hz, Ir−P(C)), -55.2 (ddd, 2JPP = 63, 4JPP = 21, 2 Hz, Ir−P(D)), -76.0 (ddd, 2JPP = 26, 4JPP = 21, 
2 Hz,  Ir−P(B)), -93.4 (m, Ir−P(A)). Anal. Calcd. for C20H45B2F8IrN4P4 (%): C, 28.90; H, 5.46; N, 
6.74. Found: C, 28.91; H, 5.21; N, 6.43. HRMS (FT-ICR): calcd for C20H45IrN4P4
2+ (M2+): 
328.1101, 329.1112. Found: m/z = 328.1097, 329.1002. Crystal data [CCDC 973860]: 
C20H45B2F8IrN4P4 (6), M = 831.30, Monoclinic, P21/c, a = 15.4119 (3) Å, b = 10.6410 (2) Å, c = 
20.2231 (14) Å, β = 102.973 (7)°, V = 3231.9 (2)  Å3, Z = 4, dcalc = 1.708 g/cm3, T = 93 K, 109528 
reflections collected, 5699 independent reflections (Rint = 0.073), final R1 = 0.1051, final wR2 = 
0.2288, GOF = 1.083. Minor Compound (7) (ca. 5 %) Selected NMR signals: 1H NMR (500 
MHz, MeOD, 25 ºC): δ 7.48, 7.32, 7.28 (CHAr), 3.92, 3.88, 3.13, 3.07 (N(CH3)), -15.4 (m, Ir−H). 
31P{1H} NMR (160 MHz, MeOD, 25 ºC):  -54.4 (Ir−P(C)), -73.6 (Ir−r(B)), -92.2 (Ir−P(A)). Crystal 
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data [CCDC 973861]: C19H44B2F8IrN4O2P3 (7), M = 819.31, Orthorhombic, P212121, a = 12.4567 
(4) Å, b = 14.2413(5) Å, c = 18.0693(13) Å, V = 3205.5(3) Å3, Z = 4, dcalc = 1.698 g/cm
3, T = 150 
K, 53405 reflections collected, 5803 independent reflections (Rint = 0.073), final R1 = 0.0371, final 
wR2 = 0.0869, GOF = 1.013. 
 [(η5-C5H5)IrIII(IMe)(Cl)](BF4) (9) 
[CpIrCl2]n (33 mg, 0.1 mmol) was suspended in CH2Cl2 (4 mL). Upon addition of dry MeCN (1 
mL) a yellow solution was obtained, which was then transferred via cannula into a suspension of 
[Ag(NHC)2]BF4 (39 mg, 0.1 mmol) in CH2Cl2 (5 mL). The mixture was stirred under exclusion 
of light for 16 hours at room temperature. The colorless precipitate was filtered off and the yellow 
solution taken to dryness under reduced pressure. The dark yellow solid was extracted with CH2Cl2 
(10 mL) by aid of brief sonication, filtered through a 0.2 μm PTFE filter, and concentrated to ~5 
mL volume. Addition of Et2O (15 mL) gave the product as bright yellow microcrystals, which 
were collected and dried in vacuo. Yield = 44 mg (77 %). 1H NMR (400 MHz, CD2Cl2, 25 ºC): δ 
= 7.07 (s, 4 H, CHAr), 5.84 (s, 5 H, C5H5), 3.48 (s, 12 H, NCH3). 
13C{1H} NMR (100 MHz, CD2Cl2, 
25 ºC): δ = 142.1 (Ir=C), 124.5 (CHAr), 83.8 (C5H5), 39.4 (NCH3). Anal. Calcd. for 
C15H21BClF4IrN4 (%): C, 31.51; H, 3.70; N, 9.80. Found: C, 31.81; H, 3.42; N, 9.57. HRMS (FT-
ICR): calcd. for C15H21ClIrN4
+ (M+): 483.1071, 485.1084. Found: m/z = 483.1056 and 485.1079. 
Crystal data [CCDC 973862]: C15H21BClF4IrN4 (9), M = 571.82, Monoclinic, P21, a = 8.4218 (4) 
Å, b = 10.3619 (4) Å, c = 10.7421 (8) Å, β = 102.256 (7)°, V = 916.05 (9)  Å3, Z = 2, dcalc = 2.073 
g/cm3, T = 93 K, 24830 reflections collected, 5230 independent reflections (Rint = 0.107), final R1 
= 0.0650, final wR2 = 0.1069, GOF = 1.062. 
 
[Ag(IBu)2](BF4) 
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This compound was prepared analogously as previously described.46 (IBu)BF4 (750 mg, 2.97 
mmol) and Ag2O (480 mg, 2.08 mmol) were dissolved in CH2Cl2 (50 mL) and a solution of NaOH 
(180 mg, 4.46 mmol) in deionized H2O (15 mL) was added. The biphasic mixture was vigorously 
stirred overnight under exclusion of light. The aqueous phase was extracted with CH2Cl2 and the 
organics combined, washed with deionized water and filtered through a hydrophobic syringe filter 
(PTFE 0.2 μm). The solution was evaporated to dryness yielding [Ag(IBu)2](BF4) as a colourless 
powder (610 mg, 88 %).1H NMR (500 MHz, CD2Cl2, 25 ºC): δ = 7.05 (s, 4 H, CHAr), 4.04 (t, 8 H, 
3JHH = 7.2 Hz, NCH2(α)), 1.76 (m, 8 H, CH2(β)), 1.28 (m, 8 H, CH2(γ)), 0.88 (t, 12 H, 3JHH = 7.4 
Hz, CH3(δ)). 13C{1H} NMR (125 MHz, CD2Cl2, 25 ºC): δ = 180.2 (d, 1JCAg = 197 Hz, Ir=C), 122.3 
(CHAr), 52.6 (NCH2(α)), 34.4 (CH2(β)), 20.6 (CH2(γ)), 14.2 (CH3(δ)). Anal. Calcd. for 
C22H40AgN4 (%): C, 47.59; H, 7.26; N, 19.43. Found: C, 47.20; H, 7.43; N, 19.10. 
1HRMS (ESI): 
calcd for C22H40AgN4
+ (M+): 467.2304. Found: m/z = 467.2308. 
[(η5-C5Me5)IrIII(IBu)(Cl)](BF4) (10) 
[Cp*IrCl2]2 (100 mg, 0.126 mmol) and [Ag(IBu)2]BF4 (140 mg, 0.252 mmol) were dissolved in 
dry CH2Cl2 (10 mL), and the resulting orange suspension stirred for 24 hours at room temperature 
under exclusion of light. The colorless precipitate was filtered off through a pad of celite and 
washed with H2O and brine. The organic phase was dried with MgSO4, filtered and evaporated to 
dryness to give compound 10 as an orange waxy solid (130 mg, 64 %). 1H NMR (500 MHz, 
CD2Cl2, 25 ºC): δ = 7.11 (s, 4 H, CHAr), 3.68 (br. s, 8 H, NCH2(α)), 1.63 – 1.45 (m, 8 H, CH2(β)), 
1.50 (s, 15 H, C5Me5), 1.25 (m, 8 H, CH2(γ)), 0.87 (t, 12 H, 3JHH = 7.4 Hz, CH3(δ)). 1H NMR (400 
MHz, CD2Cl2, -60 ºC): δ = 7.29 (br. s, 1 H, CHAr), 7.16 (br. s, 2 H, CHAr), 7.08 (br. s, 1 H, CHAr), 
4.63 (dt, 1 H, 3JHH = 12.5, 
2JHH = 4.9 Hz, NCH2(α)), 4.08 (br. t, 1 H, 3JHH = 8.5 Hz, NCH2(α)), 3.89 
(dt, 1 H, 3JHH = 12.1, 
2JHH = 4.6 Hz, NCH2(α)), 3.76 (m, 1 H, NCH2(α)), 3.89 (m, 1 H, NCH2(α)), 
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3.44 (dt, 1 H, 3JHH = 12.5, 
2JHH = 5.5 Hz, NCH2(α)), 2.97 (dt, 1 H, 3JHH = 12.2, 2JHH = 4.9 Hz, 
NCH2(α)), 2.75 (br. t, 1 H, 3JHH = 12.8, NCH2(α)), 1.84, 1.50 (br. m, 4 H each, CH2(β)), 1.55 (s, 
15 H, C5Me5), 1.48, 1.18 (br. m, 4 H each, CH2(γ)), 1.06 – 0.71 (m, 12 H, CH3(δ)). 13C{1H} NMR 
(125 MHz, CD2Cl2, 25 ºC): δ = 147.1 (Ir=C), 122.6 (br. s, CHAr), 96.6 (C5Me5), 51.1 (br. s, 
NCH2(α)), 33.3 (CH2(β)), 20.8 (CH2(γ)), 14.4 (CH3(δ)), 10.8 (C5Me5). Anal. Calcd. for 
C32H55BClF4IrN4 (%): C, 47.43; H, 6.84; N, 6.91. Found: C, 47.28; H, 6.59; N, 6.65.HRMS (FT-
ICR): calcd for C32H56IrN4
+ (MH+ – Cl): 687.4111, 689.4134. Found: m/z = 687.4112, 689.4107. 
Crystal data [CCDC 973863]: C36H63BClF4IrN4O (10), M = 882.36, Monoclinic, P21/c, a = 
13.9451 (10) Å, b = 22.7483 (4) Å, c = 13.5566 (3) Å, β = 112.440 (8)°, V = 3974.9 (3)  Å3, Z = 
4, dcalc = 1.474 g/cm
3, T = 150 K, 219215 reflections collected, 9120 independent reflections (Rint 
= 0.109), final R1 = 0.0471, final wR2 = 0.0827, GOF = 1.078. 
Catalysis. Catalytic runs were performed by charging a flame-dried Schlenk flask with 20 µmol 
Ir-complex and 0.2 mmol 1,3,5-trimethoxybenzene (TMB) as internal standard under N2 and 
adding 2 mL dry iso-propanol. After heating to the desired reaction temperature liquid substrate 
(2 mmol acetophenone) and base (0.2 mmol KOH, semiconductor grade) were added in 1 mL dry 
iso-propanol to start the reaction. Aliquots were withdrawn by syringe and quenched by mixing 
with CDCl3 in air at room temperature. After filtration through celite the solution was analyzed for 
conversion by 1H-NMR. In-situ NMR reaction progress monitoring was performed in screw-
capped 5 mm NMR tubes, charged with solid Ir-complex (0.007 mmol) and 1,3,5-
trimethoxybenzene (0.067 mmol) under N2. A solution of KOH (0.067 mmol) in dry iso-propanol 
(1 mL) was added, followed by acetophenone (78 μL, 0.67 mmol). The NMR tube was sonicated 
for 30 seconds, placed in the NMR spectrometer with the probe preheated to 60 ºC, and 1H NMR 
spectra acquired every 2 minutes. 
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Hammett studies. The procedure described above for in-situ NMR reaction progress was 
followed under competitive and non-competitive conditions. In the former case In these studies, 1 
mmol of acetophenone and 1 mmol of para-substituted acetophenone were added following 
addition of iso-propanol. First-order kinetic plots for ketone consumption allowed obtaining kH 
and kX as the first-order kinetic rate constants for acetophenone and para-substituted 
acetophenone, as well as corresponding standard deviations σH and σX derived from regression 
analysis. The Hammett plot of Figure 5 was constructed using those data and tabulated substituent 
constants (σ).52 The error bars were estimated as three standard deviations (99.7 % confidence) 
after applying error propagation calculations and assuming an error of ±0.5 K for the temperature 
of the NMR probe. 
Kinetic isotopic effect studies. The procedure described above for in-situ NMR reaction 
progress was followed for competitive and non-competitive KIE experiments using 1 and 2. In the 
former case, the reduction of the p-chloro acetophenone (used instead of acetophenone for more 
accurate integration) was followed by adding 0.5 mL of deuterated iso-propanol-(d8) and 0.5 mL 
of non-deuterated iso-propanol. Primary kinetic isotopic effects were determined as the ratio 
between non-deuterated and deuterated products, which was approximately constant over the 
reaction progress. Non-competitive KIEs (KIE = kH/kD) were determined as the ratio between first-
order kinetic rate constants obtained by the common procedure for in-situ NMR experiments 
carried out in iso-propanol (kH) and labeled iso-propanol(d8) (kD).  
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